See more : Luoyang Glass Company Limited (600876.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Plant Advanced Technologies SA (ALPAT.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Plant Advanced Technologies SA, a leading company in the Biotechnology industry within the Healthcare sector.
- Algernon Pharmaceuticals Inc. (AGNPF) Income Statement Analysis – Financial Results
- Herald Investment Trust PLC (HRI.L) Income Statement Analysis – Financial Results
- Estore Corporation (4304.T) Income Statement Analysis – Financial Results
- Exco Technologies Limited (XTC.TO) Income Statement Analysis – Financial Results
- SAN Holdings, Inc. (9628.T) Income Statement Analysis – Financial Results
Plant Advanced Technologies SA (ALPAT.PA)
About Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include PAT Plant Milking that produces active extracts through plant stimulation and living-root exudation while preserving plants; PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes; and PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous plants to produce outside their leaf in a sterile closed pitcher. The company was founded in 2005 and is headquartered in Vanduvre-lès-Nancy, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.68M | 2.34M | 2.31M | 1.72M | 1.17M | 1.87K | 1.46K | 1.58K | 1.88K | 1.68K | 1.21M | 917.00K |
| Cost of Revenue | -471.40K | 6.99M | 5.03M | 4.54M | 2.43M | 1.23K | 865.91 | 861.11 | 1.15K | 1.07K | -415.62K | -437.92K |
| Gross Profit | 2.15M | -4.65M | -2.73M | -2.82M | -1.26M | 640.85 | 596.48 | 716.01 | 730.23 | 615.76 | 1.62M | 1.35M |
| Gross Profit Ratio | 128.03% | -198.89% | -118.31% | -164.22% | -107.47% | 34.22% | 40.79% | 45.40% | 38.85% | 36.57% | 134.45% | 147.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 1.05M | 1.04M | 702.92K | 1.06M | 904.44K | 876.00K | 1.19M | 972.87K | 603.46K | 538.33K |
| Selling & Marketing | 0.00 | 0.00 | -976.58K | -973.81K | -648.55K | -1.06M | -902.54K | -874.28K | -1.19M | -971.66K | 0.00 | 0.00 |
| SG&A | 0.00 | 32.00K | 73.00K | 69.00K | 54.37K | 1.83K | 1.90K | 1.72K | 1.47K | 1.20K | 603.46K | 538.33K |
| Other Expenses | 2.93M | 2.82M | -237.00K | 46.00K | -197.61K | -3.26M | -42.17K | 221.00K | 3.61K | 0.00 | 189.97K | -40.00K |
| Operating Expenses | 2.93M | -2.79M | 310.00K | 23.00K | 251.98K | 533.81 | 2.09K | 2.58K | 2.25K | 1.73K | 2.03M | 1.52M |
| Cost & Expenses | 2.46M | 4.20M | 5.34M | 4.57M | 2.69M | 1.77K | 2.96K | 3.44K | 3.40K | 2.80K | 1.62M | 1.08M |
| Interest Income | 0.00 | 107.00 | 115.00 | 3.00K | 12.93K | 92.28 | 61.79 | 51.27 | 68.95 | 66.47 | 1.22K | 591.00 |
| Interest Expense | 112.73K | 107.00K | 115.00K | 112.00K | 84.60K | 92.87K | 62.37K | 81.25K | 79.75K | 67.66K | 33.80K | 15.62K |
| Depreciation & Amortization | 513.54K | 1.06M | 787.00K | 643.00K | 405.05K | 573.90K | 495.06K | 559.09K | 547.76 | 434.65 | 679.35K | 339.74K |
| EBITDA | 72.53K | -807.00K | -1.27M | -819.00K | -854.12K | 681.53K | -1.01M | -1.28M | -702.02K | -674.89K | -73.48K | 136.67K |
| EBITDA Ratio | 4.31% | -34.50% | -97.61% | -128.16% | -94.42% | -91.18% | -99.78% | -81.32% | -42.89% | -38.45% | 67.83% | 15.82% |
| Operating Income | -778.24K | -1.86M | -3.04M | -2.85M | -1.51M | -2.11K | -1.87K | -1.84K | -1.35K | -1.08K | -409.23K | -163.66K |
| Operating Income Ratio | -46.28% | -79.61% | -131.76% | -165.56% | -128.95% | -112.95% | -127.65% | -116.79% | -72.03% | -64.26% | -33.92% | -17.85% |
| Total Other Income/Expenses | 224.50K | -36.00K | -52.00K | 529.00K | 168.63K | 2.84M | 308.17K | -74.12K | 22.21K | -127.37K | 168.73K | -55.02K |
| Income Before Tax | -553.73K | -1.91M | -2.17M | -1.57M | -1.34M | 14.76 | -1.56K | -1.92K | -1.59K | -1.18K | -240.50K | -218.69K |
| Income Before Tax Ratio | -32.93% | -81.49% | -94.06% | -91.56% | -114.58% | 0.79% | -106.57% | -121.49% | -84.68% | -70.06% | -19.93% | -23.85% |
| Income Tax Expense | -632.90K | -1.07M | -1.06M | -1.05M | -802.53K | 849.74 | 883.73 | 790.73 | 696.84 | 585.17 | 418.53K | 292.39K |
| Net Income | 79.17K | -849.00K | -1.13M | -543.00K | -541.23K | 864.51 | -674.79 | -1.13K | -894.93 | -594.63 | -66.03K | 259.34K |
| Net Income Ratio | 4.71% | -36.30% | -49.20% | -31.59% | -46.15% | 46.17% | -46.14% | -71.36% | -47.61% | -35.31% | -5.47% | 28.28% |
| EPS | 0.07 | -0.78 | -1.04 | -0.50 | -0.50 | 0.88 | -0.73 | -1.25 | -0.99 | -0.93 | -0.11 | -0.52 |
| EPS Diluted | 0.07 | -0.78 | -1.04 | -0.50 | -0.50 | 0.88 | -0.73 | -1.25 | -0.99 | -0.93 | -0.11 | -0.52 |
| Weighted Avg Shares Out | 1.13M | 1.09M | 1.09M | 1.08M | 1.08M | 982.00 | 921.00 | 898.00 | 903.00 | 639.00 | 600.23K | 982.39K |
| Weighted Avg Shares Out (Dil) | 1.13M | 1.09M | 1.09M | 1.08M | 1.08M | 982.39 | 921.41 | 898.76 | 903.97 | 639.39 | 600.23K | 982.39K |
Source: https://incomestatements.info
Category: Stock Reports